Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
Publication date: Available online 7 August 2017 Source:Journal of Allergy and Clinical Immunology Author(s): Phillip L. Lieberman, Ilisten Jones, Richa Rajwanshi, Karin Rosén, Dale T. Umetsu
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2fnArdu
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου